Evaluation of 6 years of group B streptococcus (GBS) screening in near-term pregnant women

Streptococcus agalactiae (GBS) is a significant cause of morbidity and mortality among newborns. Colonization frequently occurs in pregnant women, nearly all international recommendations suggest that all pregnant women must be screened for vaginal colonization at 34 to 37 weeks of gestation. The mi...

Full description

Saved in:
Bibliographic Details
Published in:Pathologie biologie (Paris) 2010-04, Vol.58 (2), p.144-146
Main Authors: Honderlick, P, Gravisse, J, Cahen, P, Vignon, D
Format: Article
Language:fre
Subjects:
Adult
Carrier State - epidemiology
Carrier State - microbiology
Female
France - epidemiology
Humans
Infant, Newborn
Infectious Disease Transmission, Vertical - prevention & control
Mass Screening
Morbidity - trends
Neonatal Screening
Pregnancy
Pregnancy Trimester, Third
Prevalence
Retrospective Studies
Streptococcal Infections - congenital
Streptococcal Infections - epidemiology
Streptococcal Infections - microbiology
Streptococcal Infections - prevention & control
Streptococcal Infections - transmission
Streptococcus agalactiae - immunology
Streptococcus agalactiae - isolation & purification
Vagina - microbiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Streptococcus agalactiae (GBS) is a significant cause of morbidity and mortality among newborns. Colonization frequently occurs in pregnant women, nearly all international recommendations suggest that all pregnant women must be screened for vaginal colonization at 34 to 37 weeks of gestation. The microbiological diagnostic modalities used to combat GBS had to be accurate and in short time frame. We reported a 6 years experience of GBS screening, comparing results of culture swab of prenatal vaginal specimens and newborns colonization or infection. The carriage rate of 13 to 14% of GBS in newborn was unchanged during all the study period.
ISSN:1768-3114
DOI:10.1016/j.patbio.2009.07.010